Asset Details
Do you wish to reserve the book?
Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes
Do you wish to request the book?
Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes
2024
Overview
BackgroundRandomized clinical trials (RCTs) generally assess efficacy and safety separately, with the conclusion of whether a treatment is beneficial based solely on the efficacy endpoint. However, assessing and combining efficacy and safety domains, using a single composite outcome measure, can provide a more comprehensive assessment of the overall effect of a treatment. Furthermore, composite outcomes can incorporate information regarding the relationship between the individual outcomes. In fact, such outcomes have been suggested in the clinical trials literature for at least 15 years.ObjectivesTo (1) identify whether recent primary publications of chronic pain RCTs from major pain journals included a composite outcome measure of benefits and harms and (2) discuss the potential benefits of such outcomes in various stages of treatment development, including as outcome measures in RCTs, and to support decisions of Data and Safety Monitoring Boards and ordering of treatments in the context of treatment guidelines.Evidence reviewRCTs published in 6 major pain journals published between 2016 and 2021 that investigated interventions for chronic pain were reviewed.FindingsOf 73 RCTs identified, only 2 included a composite outcome measure of benefits and harms. Both of these articles compared 2 active treatments.ConclusionsComposite outcomes of benefits and harms are underutilized in chronic pain RCTs. The advantages and challenges of using such outcomes are discussed.
Publisher
BMJ Publishing Group Ltd,BMJ Publishing Group LTD
